Millennium Post

Govt to bring AYUSH under regulatory framework

The manufacturing and pricing of indigenous drugs will no more be left to the whims and fancies of leading Ayurvedic medicine manufacturers such as Himalaya, Dabur, Baidyanath and Charak.

Reason: The Narendra Modi-led NDA government at the centre has set up two regulatory bodies to figure out ill practises in the domestic form of treatment. Not only this, the Union Health Ministry has also brought doctors practising AYUSH under the ambit of a separate regulator.  

In a written reply to Rajya Sabha, Minister of State for Health Shripad Naik said, “ As health being a state subject, the practice of AYUSH (Ayurveda, Siddha, Homeopathy and Unani) doctors is regulated by the respective state. However, the Centre has set up two regulatory bodies —Central Council of Indian Medicine (CCIM) Central Council of Homoeopathy (CCH).”

The CCIM has been set up under Indian Medicine Central Council (IMCC) Act 1970 for regulation of educational institutions and practitioners in respect of Ayurveda, Unani and Sidha systems of medicines and CCIM under Homoeopathy Central Council Act, 1973 for regulation of educational institutions and practitioners in respect of homoeopathy system of medicines. It is pertinent to mention here that at present yoga and naturopathy, being drugless systems, is not regulated.

While elaborating about the powers of regulatory authority, a health official said that the  body will function on lines of Drugs Controller General of India (DCGI), which currently looks at all medicines sold in the country. However, like in the case of pharmaceuticals or allopathic products, licensing and approval of AYUSH products will continue to be under the purview of state drug regulatory authorities, which coordinate and follow standards set by the central authority.

According to the latest Health Ministry report, there are only nine colleges of Siddha, while 281 colleges of Ayurveda, 44 institutions of Unani and 191 colleges of Homoeopathy in the country.

Next Story
Share it